Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 4,642 | 5,845 | 5,008 | 3,001 | 834 |
| Cost of Goods | 3,786 | 3,239 | 2,190 | 1,231 | 343 |
| Gross Profit | 856 | 2,606 | 2,818 | 1,770 | 491 |
| Operating Expenses | 9,109 | 7,105 | 6,976 | 7,922 | 8,264 |
| Operating Income | -7,467 | -4,260 | -3,968 | -5,921 | -7,430 |
| Interest Expense | 3 | 3 | 2 | 2 | 2 |
| Other Income | 134 | 557 | 758 | 1,342 | -21 |
| Pre-tax Income | -7,336 | -3,706 | -3,212 | -4,581 | -7,453 |
| Income Tax | 0 | N/A | N/A | 412 | N/A |
| Net Income Continuous | -7,336 | -3,706 | -3,212 | -4,993 | -7,453 |
| Net Income | $-7,336 | $-3,706 | $-3,212 | $-4,993 | $-7,453 |
| EPS Basic Total Ops | -1.20 | -0.60 | -0.60 | -0.80 | -1.40 |
| EPS Basic Continuous Ops | -1.22 | -0.63 | -0.56 | -0.89 | -1.34 |
| EPS Diluted Total Ops | -1.20 | -0.60 | -0.60 | -0.80 | -1.40 |
| EPS Diluted Continuous Ops | -1.22 | -0.63 | -0.56 | -0.89 | -1.34 |
| EBITDA(a) | $-7,063 | $-3,844 | $-3,473 | $-5,441 | $-6,891 |